Form 4 for MRNA Moderna
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-12 · accession 0001127602-22-022417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-14 | 2022-09-12+ | MRNA | Hoge Stephen | Pres | M - OptEx | $10.90 | +6,972 | 1.63M | +0.4% | +$76.0K |
| DM | 2022-09-14 | 2022-09-12+ | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.18 | -6,972 | 1.63M | -0.4% | -$977.3K |
| DM | 2022-09-14 | 2022-09-12+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -6,972 | 1,972 | -78% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-12 | M | A | 5,000 | $10.90 | 1,630,800 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-12 | S | D | 5,000 | $141.66 | 1,625,800 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-13 | M | A | 1,972 | $10.90 | 1,627,772 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-13 | S | D | 1,972 | $136.42 | 1,625,800 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-09-13 | M | D | 1,972 | $0.00 | 0 | D | $10.90 · — to 2026-02-23 | 1,972 Common Stock | (F3) This option is fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-09-12 | M | D | 5,000 | $0.00 | 1,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F3) This option is fully vested and exercisable. |